Third Harmonic Bio Inc Net Income per Employee (THRD), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Third Harmonic Bio Inc   (NASDAQ: THRD)
 

Third Harmonic Bio Inc Net Income per Employee

THRD's Quarterly Results, Trends, Rankings, Statistics
Third Harmonic Bio Inc 's Income per employee fell in the first quarter 2025 on a trailing twelve month basis to $ 1,008,434, below the company average number of $570,038.
The Healthcare sector has seen employees of 11 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 169, from total ranking in previous quarter at 189.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

THRD Net Income per Employee (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Net Income Change 101.55 % 91.73 % 87.92 % 41.63 % -13.53 %
Net Income per Employee (TTM) $ 1,008,434 857,906 739,585 617,774 558,396
THRD's Total Ranking # 169 # 189 # 204 # 0 # 0
Seq. Net Income Change 20.81 % -5.01 % 28.88 % 36.29 % 14.92 %

THRD Company Profile >> Back to THRD Efficiency Comparisons >> Compare THRD Net Income per Employee to its Competitors

THRD Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 12
Healthcare Sector # 20
Overall Market # 169

Net Income per Employee Statistics
High Average Low
$ 1,008,434 $ 570,038 $ 154,811
(Mar 31 2025)   (Sep 30 2022)







Companies with similar Income per Employee for 12 month ending Mar 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2025Number of Employees Mar 31 2025
Pavmed Inc   1,599,073.17 $ 65.562  Million 41 
Alumis inc   1,320,937.50 $ 295.890  Million 224 
Exelixis Inc   1,291,742.81 $ 1,481.629  Million 1,147 
Outlook Therapeutics Inc   1,242,404.47 $ 21.121  Million 17 
Agios Pharmaceuticals Inc   1,233,305.56 $ 665.985  Million 540 
Whitehawk Therapeutics Inc   1,200,608.70 $ 27.614  Million 23 
Halozyme Therapeutics Inc   1,147,430.26 $ 485.363  Million 423 
Seres Therapeutics Inc   1,105,318.18 $ 72.951  Million 66 
Catalyst Pharmaceuticals Inc   1,084,346.15 $ 197.351  Million 182 
Third Harmonic Bio Inc   1,008,433.96 $ 53.447  Million 53 
Siga Technologies Inc  990,380.67 $ 48.529  Million 49 
Minerva Neurosciences Inc   893,528.29 $ 6.255  Million 7 
Prestige Consumer Healthcare Inc   875,077.19 $ 498.794  Million 570 
United Therapeutics Corporation  864,785.71 $ 1,210.700  Million 1,400 
Nkgen Biotech Inc   655,730.77 $ 17.049  Million 26 
Novavax inc   639,114.82 $ 478.697  Million 749 
Cytomx Therapeutics Inc   602,942.03 $ 41.603  Million 69 
Ptc Therapeutics inc   600,245.21 $ 594.843  Million 991 
Bluebird Bio Inc   562,250.00 $ 139.438  Million 248 
Nutriband Inc   542,111.60 $ 2.711  Million 5 
Harmony Biosciences Holdings inc   521,225.26 $ 152.719  Million 293 


Date modified: 2026-09-08T15:11:30+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.